GoHealth (GOCO) Company Report

GoHealth reported net revenues of $118.3 million for Q3 2024, a decrease from $132.0 million in Q3 2023.
The company's Adjusted EBITDA for Q3 2024 was -$12.1 million, a slight decline compared to -$11.5 million in Q3 2023.
Despite the quarterly decline, trailing twelve months (TTM) Adjusted EBITDA significantly improved to $59.5 million for the period ending Q3 2024, up from -$76.7 million for the TTM ending Q3 2023.
Net income for Q3 2024 was $15.4 million, a substantial improvement from a net loss of $56.2 million in Q3 2023.
TTM cash flow from operations turned positive at $35.1 million for the period ending Q3 2024, compared to -$3.2 million for the TTM ending Q3 2023.

Nov 13, 2025, 1:00 PM

Presentation

GoHealth Reports Q3 2025 Results

GOCO

Earnings

Profit Warning

Demand Weakening

GoHealth reported net revenues of $34,186 for the third quarter of 2025.
The company posted a net loss of $(313,918) and Adjusted EBITDA of $(47,090) for Q3 2025, resulting in an Adjusted EBITDA Margin of (137.7)%.
Third quarter 2025 results included significant indefinite and long-lived asset impairment charges of $206,163 and a loss on extinguishment of debt of $1,655.

Nov 13, 2025, 1:00 PM

Presentation

GoHealth (GOCO) Scales Back Medicare Advantage Volume and Focuses on Retention and Special Needs Plans in Q3 2025

GOCO

Debt Issuance

New Projects/Investments

Demand Weakening

GoHealth deliberately scaled back its Medicare Advantage (MA) activity in Q2 2025 due to tightening health plan economics, reduced pre-funded marketing, and adjusted broker compensation, prioritizing quality, retention, and cash preservation over volume.
The company reported approximately $32 million in cash at the end of Q3 2025 and secured a $40 million new senior-secured super priority term loan facility to maintain liquidity and strategic flexibility.
GoHealth is aligning its strategy with health plan priorities, focusing on member retention and its leadership position in special needs plans (SNPs), where health plans are increasingly reallocating resources and total available non-special needs plan products declined for 2026.
Management believes the fragmented broker landscape supports industry consolidation and that GoHealth is positioned to lead integration given its strengthened balance sheet and lender support.

Nov 13, 2025, 1:00 PM

Transcript

GoHealth Reports Q3 2025 Results Amid Strategic Market Pullback

GOCO

Earnings

Board Change

Debt Issuance

GoHealth, Inc. reported net revenues of $34,186 thousand and a net loss attributable to GoHealth, Inc. of $(165,846) thousand for the third quarter ended September 30, 2025. The basic net loss per share of Class A common stock was $(11.80), and Adjusted EBITDA was $(47,090) thousand for the quarter.
The company implemented a disciplined pullback strategy, intentionally reducing Medicare Advantage volume in response to a market shift towards renewal stability, member quality, and unit economics.
This strategy emphasizes a retention-first approach, leadership in Special Needs Plans, and preserving core strategic capabilities for future market stabilization.
To strengthen strategic flexibility, GoHealth secured a superpriority term loan facility, received covenant relief, and refreshed its Board of Directors.

Nov 13, 2025, 12:03 PM

8-K

GoHealth Reports Q3 2025 Results and Strategic Shift

GOCO

Earnings

Demand Weakening

Board Change

GoHealth reported a net loss attributable to GoHealth, Inc. of $(165.846) million for the third quarter ended September 30, 2025, compared to a net income of $6.775 million in the prior year period, with net revenues decreasing to $34.186 million from $118.292 million. For the nine months ended September 30, 2025, the company also reported a net loss of $(224.531) million on net revenues of $349.206 million.
The company implemented a disciplined pullback by intentionally reducing Medicare Advantage volume and aligning its operating model with a focus on retention, member quality, and disciplined unit economics, in response to a market shift where health plans prioritize margin integrity and renewal stability.
To strengthen strategic flexibility, GoHealth secured a superpriority term loan facility, received covenant relief, and refreshed its Board of Directors to enable potential integration and consolidation opportunities.

Nov 13, 2025, 12:00 PM

Press Release

GoHealth Inc. Highlights Business Performance and Strategic Initiatives

GOCO

Product Launch

New Projects/Investments

GoHealth is a leading health insurance marketplace focused on Medicare, having facilitated 1M+ Medicare plan submissions in 2024A1 and ranking as the #1 Medicare Enroller for a majority of its health plan partners in AEP Q4 2023 and Q4 2024.
The company demonstrates strong operational efficiency, with a Direct Operating Cost per Submission of $578 in FY24, which is 17-31% lower than its peers.
GoHealth leverages proprietary AI-powered PlanFit technology for consumer targeting, personalized plan matching, and retention through its PlanFit Save program, aiming to optimize enrollment and reduce member churn.
The company operates in a large and expanding market, with Medicare Advantage enrollment projected to grow to 42 million by 2030.

Aug 7, 2025, 11:00 AM

Presentation

GoHealth Announces Strategic Capital and Governance Actions and Q2 2025 Results

GOCO

Debt Issuance

Board Change

Earnings

GoHealth announced strategic capital actions, including securing a new senior secured superpriority term loan facility of $115.0 million (with $80.0 million in new-money and $35.0 million in roll-up loans) maturing on August 5, 2029, to enhance financial flexibility and support working capital.
The company amended its existing credit agreement, waiving near-term principal payments through 2026, resetting financial covenants, and creating $250.0 million in debt basket capacity for potential transformative transactions.
As part of these strategic actions, GoHealth issued 4,766,219 shares of Class A common stock to lenders, representing 19.99% of the total outstanding Class A and Class B common stock.
For the second quarter ended June 30, 2025, GoHealth reported net revenues of $94,048 thousand and a net loss attributable to GoHealth, Inc. of $(54,277) thousand, which includes $53,000 thousand in intangible asset impairment charges.
The Board of Directors appointed three new directors and established a Transformation Committee to review strategic alternatives, aligning governance with the company's strategic direction.

Aug 7, 2025, 12:00 AM

8-K

GoHealth details AI-driven growth, cost efficiency, and strategic life-insurance pivot

GOCO

Guidance Update

Leading Medicare Advantage platform: GoHealth has facilitated over 30 million shopping experiences and 1 million+ enrollments in 2024, serving as the #1 source of enrollments for each major health plan.
AI-enabled, telephonic model: Utilizes proprietary Plan Fit tool for unbiased plan matching via live licensed agents, offering 85%+ of Medicare Advantage plans nationally and “plan fit checkups” that even recommend staying on a consumer’s current plan if optimal.
Industry-leading cost efficiencies: Reduced direct operating cost per submission by 60% since 2022, outperforming public peers by 17% and the industry by 50% in 2024 through automation and standardized workflows.
Strategic pivot amid plan headwinds: In response to health plans’ growth pullback in Q4 2024/Q1 2025, GoHealth paused new Medicare Advantage sales in Q2–Q3 and redeployed agents to sell guaranteed-acceptance life insurance, with material revenue expected starting Q2 2025.
2025 AEP outlook: Expects a disruptive Annual Enrollment Period as plan exits rise, driving high-intent consumers to its platform, with growth contingent on agent capacity and health plan partner strategies.

Jun 12, 2025, 3:41 PM

GoHealth Inc Reports Q1 2025 Earnings Results

GOCO

Earnings

Revenue Acceleration/Inflection

Financial Metrics

Product Launch

Revenue increased to $221.0M in Q1 2025, up 19% YoY from $185.6M, with adjusted EBITDA rising to $42.1M (up 56% YoY)
Enhanced operational efficiencies with improved unit economics: Sales per Submission at $724 and Direct Operating Cost per Submission at $522 (an 18% reduction from $640), plus an improved agent productivity framework
Ending Commissions Receivable rose to $1,000.6M while cash flow from operations turned negative at ($12.4M), contrasting with $12.5M positive cash flow in the prior year
Continued diversification with the launch and testing of GoHealth Protect, a guaranteed acceptance life insurance product, alongside ongoing innovation in the PlanFit platform

May 13, 2025, 12:00 PM

Transcript Presentation

GoHealth Reports Strong Q4 2024 and FY 2024 Financial & Operational Performance

GOCO

Earnings

Revenue Acceleration/Inflection

Debt Issuance

Q4 2024 Highlights: Revenue reached $389.1M (up 41% YoY), with 481,445 submissions (up 67%) and a net income improvement of $60.3M; adjusted EBITDA climbed to $117.8M with a 107% improvement
Fiscal Year 2024 Performance: Revenue totaled $798.9M (up 9% YoY), with adjusted EBITDA increasing to $120.3M, alongside 1,016,182 submissions (up 23%) and a reported net loss of $7.3M
Enhanced Operational Efficiency: Medicare unit economics improved with customer acquisition costs dropping 27% from $688 to $501 and sales per submission falling from 957 to 804
Digital Engagement & Technology Integration: Integration of e-TeleQuote and 72% YoY growth in PlanFit Checkup initiatives underscored the company’s digital focus
Strengthened Financial Position: Successfully refinanced a $475M term loan facility maturing in 2029, reinforcing long-term growth prospects